Business Standard

Asian Paints, BoB to replace R-Power, RCom in Nifty

Related News

The National Stock Exchange on Wednesday said it would exclude two Group companies — and — from its benchmark from April 27. These two companies will be replaced by and in the 50-share index.

In August 2011, the Bombay Stock Exchange had exclude Reliance Infrastructure and Reliance Communications — from its benchmark Sensex.

Read more on:   
|
|
|
|
|
|
|

Asian Paints, BoB to replace R-Power, RCom in Nifty

The National Stock Exchange on Wednesday said it would exclude two Anil Dhirubhai Ambani Group companies — Reliance Power and Reliance Communications — from its benchmark Nifty index from April 27. These two companies will be replaced by Asian Paints and Bank of Baroda in the 50-share index.

The National Stock Exchange on Wednesday said it would exclude two Group companies — and — from its benchmark from April 27. These two companies will be replaced by and in the 50-share index.

In August 2011, the Bombay Stock Exchange had exclude Reliance Infrastructure and Reliance Communications — from its benchmark Sensex.

image

Read More

IABF to close $120-mn fund this year

India Agri Business Fund (IABF), a $120- million equity fund instituted in 2008 for which Rabo Equity Advisors is an investment advisor, is planning ...

Recommended for you

Quick Links

Market News

RCom, BPCL plan to launch dollar bonds

For RCom, it will be second time the Ambani company is testing the investors' appetite for its paper

BSE currency options segment largest in the world

Number of contracts in currency options segment had grown by nearly 30% in March

Nifty ends down 101 points; TCS down 4%, Lupin slumps 7%

The 30-share Sensex ended down 224 points at 28,442 and the 50-share Nifty ended down 101 points at 8,606.

Sensex ends down 242 points; IT shares drag

The 30-share Sensex provisionally ended down 242 points at 28,425 and the 50-share Nifty ended down 104 points at 8,603.

Pharma shares extend fall; CNX Pharma index down 3%

Lupin, Aurobindo, Sun Pharma, Cadila Healthcare, Venus Remedies, SPARC & Shasun Pharma down were 3%-7%.

 

Back to Top